Health Technology Assessment (Jun 2006)

A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1

  • M Connock,
  • A Juarez-Garcia,
  • E Frew,
  • A Mans,
  • J Dretzke,
  • A Fry-Smith,
  • D Moore

DOI
https://doi.org/10.3310/hta10200
Journal volume & issue
Vol. 10, no. 20

Abstract

Read online

No abstracts available.